AG
LYEL icon

Artal Group’s Lyell Immunopharma LYEL Stock Holding History

Artal Group’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-35,000
Closed -$2.43M – 130
2022
Q4 		$2.43M Hold
35,000
– – 0.14% 81
2022
Q3 		$5.13M Hold
35,000
– – 0.22% 59
2022
Q2 		$4.56M Hold
35,000
– – 0.24% 63
2022
Q1 		$3.54M Hold
35,000
– – 0.15% 95
2021
Q4 		$5.42M Hold
35,000
– – 0.15% 99
2021
Q3 		$10.4M Hold
35,000
– – 0.23% 79
2021
Q2 		$11.4M Buy
+35,000
New +$11.5M 0.23% 83

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

Artal Group's LYEL Position: Q1 2023 in Review

Artal Group sold out of Lyell Immunopharma (LYEL) in Q1 2023, closing a stake of 35,000 shares — an estimated $2.43M sold.

Artal Group first reported a position in LYEL in Q2 2021 and held it in 7 quarters. The position peaked at $11.4M in Q2 2021. 99 funds tracked by Wall St. Rank hold LYEL as of Q1 2023.

  • Artal Group reported no remaining Lyell Immunopharma position as of Q1 2023 after selling out during the quarter.
  • Artal Group sold 35,000 Lyell Immunopharma shares in Q1 2023, an estimated $2.43M.
  • Artal Group first reported a position in Lyell Immunopharma in Q2 2021 and held it in 7 quarters.
  • Artal Group's Lyell Immunopharma position peaked at $11.4M in Q2 2021.
  • 99 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2023.

Based on Artal Group's 13F filing for Q1 2023, filed 12 May 2023.